This face to face meeting was attended in person by the company (Dr Itescu and others) and Dr. Nicole Verdun – being the newly appointed permanent Director of the FDA’s Centre for Biologics Evaluation and Research Office Of Therapeutic Products. The presence of senior leadership from the FDA is an encouraging sign of the intent of the Agency to facilitate an approval for Remestemcel-L
I think they are going for home base without selling the farm.
Its now up to Jane Bell it seems.
Aloha.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-16994
-
- There are more pages in this discussion • 922 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
97.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 7329 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
92.0¢ | 2290 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 7329 | 1.015 |
1 | 173 | 1.005 |
1 | 962 | 1.000 |
3 | 75522 | 0.990 |
2 | 691 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
0.920 | 2290 | 2 |
0.925 | 16144 | 1 |
0.935 | 5935 | 1 |
0.940 | 4609 | 2 |
0.970 | 103 | 1 |
Last trade - 09.57am 13/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online